Effect of felbamate on the pharmacokinetics of clonazepam

American Journal of Therapeutics

Volumn 3, Issue 4, 1996, Pages 294-297

  Colucci, R ^a,c   Glue, P ^a   Banfield, C ^a   Reidenberg, P ^a   Meehan, J ^a   Radwanski, E ^a   Korduba, C ^a   Lin, C ^a   Dogterom, P ^b   Ebels, T ^b   Hendriks, G ^b   Jonkman, J H G ^b   Affrime, M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PRA International USA   (Netherlands)

^c Clinical Research   (United States)

Author keywords

clonazepam; felbamate; pharmacokinetics

Indexed keywords

7 ACETAMIDOCLONAZEPAM; 7 AMINOCLONAZEPAM; CLONAZEPAM; DRUG METABOLITE; FELBAMATE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG POTENTIATION; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTOXICITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 8944221189     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199604000-00007     Document Type: Article

References (19)

1. Palmer KJ, McTavish D: Felbamate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 1992;45:1041-1065.
2. Graves NM: Felbamate. Ann Pharmacotherapy 1993;27: 1073-1081.
3. 14C felbamate in healthy men. [Abstract]. Epilepsia 1990;31:642.
4. Graves NM, Holmes GB, Fuerst RH et al: Effect of felbamate on phenytoin and carbamazepine serum concentrations. Epilepsia 1989;30:225-229.
5. Reidenberg P, Glue P, Banfield C et al: Effects of felbamate on the pharmacokinetics of phenobarbital. Manuscript under submission.
6. Wagner ML, Graves NM, Leppik IE et al: The effect of felbamate on valproic acid disposition. Clin Pharmacol Ther 1994;56:494-502.
7. Wagner ML, Remmel RP, Graves NM et al: Effect of felbamate on carbamazepine and its major metabolites. Clin Pharmacol Ther 1993;53:536-543.
8. Sato S: Clonazepam. In: Antiepileptic Drugs, 3rd ed. (Eds. Levy R., Mattson R, Meldrum B et al) Raven Press, New York, 1989, pp. 765-784.
9. Holmes GL: Critical issues in the treatment of epilepsy. Am J Hosp Pharm 1993;50(Suppl 5):S5-S16.
10. Saavedra IM, Aguilera I, Faure E et al: Phenytoin/ clonazepam interaction. Ther Drug Monitoring 1985;7: 481-484.
11. Lai AA, Levy RH, Cutler RE: Time course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther 1978;24:315-323.
12. Sunaoshi W, Miura H, Shirai H: Influence of concurrent administration of carbamazepine on the plasma concentrations of clonazepam. Jpn J Psychiat Neurology 1988;42: 589-591.
13. Nanda RN, Johnson RH, Keogh HJ et al: Treatment of epilepsy with clonazepam and its effects on other anticonvulsants. J Neurol Neurosurg Psychiat 1977;40:538-543.
14. Khoo K-C, Mendels J, Rothbart M et al: Influence of phenytoin and phenobarbitone on the disposition of a single oral dose of clonazepam. Clin Pharmacol Ther 1980;28:368-375.
15. Gibaldi M, Perrier D: Pharmacokinetics, 2nd ed., Marcel Dekker, Inc., New York, 1982.
16. Saano V, Glue P, Banfield C et al: Effects of felbamate on the pharmacokinetics of a low dose combination oral contraceptive. Clin Pharmacol Ther (In press).
17. Guengerich FP, Martin MV, Beaune P et al: Characterization of rat and human liver microsomal cytochrome p-450 forms involved in the nifedipine oxidation, a prototype for genetric polymorphism in oxidative drug metabolism. J Biol Chem 1986;261:5051-5060.
18. Seree EJ, Pisano PJ, Placidi M et al: Identification of the human and animal hepatic cytochromes P450 involved in clonazepam metabolism. Fundam Clin Pharmacol 1993;7:69-75.
19. Evans DAP: N-Acetyltransferase. Pharmacol Ther 1989; 42:157-234.